How Concerning Are the Allergic Reactions to Pfizer’s and Moderna’s Vaccines?

1 min read

There have been several reports of individuals receiving the COVID-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) and experiencing serious allergic reactions. The advisory panel to the U.S. Food and Drug Administration (FDA) that reviewed Moderna‘s (NASDAQ: MRNA) coronavirus vaccine focused on the potential for similar reactions. In this Motley Fool Live video recorded on Dec. 18, 2020, healthcare and cannabis bureau chief Corinne Cardina and writer Keith Speights discuss how big of a concern these allergic reactions should be.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Alarm Bells Ring for Amazon as This Rival Upstart Hits an Important Milestone

Next Story

2 Must-Own Stocks in 2021

Latest from Blog